|
SEL1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.00139999981953E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.588200E-04 |
| Normal-vs-Stage2 |
4.482200E-03 |
| Normal-vs-Stage3 |
2.85779999997793E-06 |
| Normal-vs-Stage4 |
6.34499999985216E-07 |
| Stage1-vs-Stage2 |
4.958000E-01 |
| Stage1-vs-Stage3 |
4.079500E-02 |
| Stage1-vs-Stage4 |
1.389940E-02 |
| Stage2-vs-Stage3 |
4.667400E-01 |
| Stage2-vs-Stage4 |
2.461200E-01 |
| Stage3-vs-Stage4 |
6.208600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.06890000004267E-06 |
| Normal-vs-AfricanAmerican |
2.56860000047432E-07 |
| Normal-vs-Asian |
1.373820E-01 |
| Caucasian-vs-AfricanAmerican |
2.803700E-02 |
| Caucasian-vs-Asian |
8.882000E-01 |
| AfricanAmerican-vs-Asian |
3.042200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43450000003698E-06 |
| Normal-vs-Female |
3.90869999999932E-05 |
| Male-vs-Female |
9.443800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.015900E-04 |
| Normal-vs-Age(41-60Yrs) |
6.46149999999901E-05 |
| Normal-vs-Age(61-80Yrs) |
3.94079999999075E-06 |
| Normal-vs-Age(81-100Yrs) |
2.620500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.583200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.641800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.380000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.700800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.487400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.442800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.970200E-01 |
| Normal-vs-Grade 2 |
4.793800E-04 |
| Normal-vs-Grade 3 |
3.36249999954852E-07 |
| Normal-vs-Grade 4 |
7.19039999985682E-07 |
| Grade 1-vs-Grade 2 |
2.625200E-01 |
| Grade 1-vs-Grade 3 |
6.643600E-02 |
| Grade 1-vs-Grade 4 |
2.006400E-02 |
| Grade 2-vs-Grade 3 |
5.958300E-02 |
| Grade 2-vs-Grade 4 |
2.995600E-02 |
| Grade 3-vs-Grade 4 |
4.190200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.178700E-04 |
| Normal-vs-ccB subtype |
2.380100E-03 |
| ccA subtype-vs-ccB subtype |
8.889400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.430120E-04 |
| Normal-vs-N1 |
2.496200E-03 |
| N0-vs-N1 |
3.549400E-01 |
|
|
